about
Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a referenceAnoctamin 1 is apically expressed on thyroid follicular cells and contributes to ATP- and calcium-activated iodide effluxTensegrity model hypothesis: may this paradigm be useful to explain hepatic and pancreatic carcinogenesis in patients with persistent hepatitis B or hepatitis C virus infection?RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States womenAllele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutationRET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations.Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies.RET oncogene activation in papillary thyroid carcinoma.Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions.A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.KRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer.Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.Clinical experience with gefitinib: an update.Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomasCigarette smoking and risk of non-Hodgkin lymphoma subtypes among womenPrimary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patientsTall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.Malignant ectomesenchymoma: genetic profile reflects rhabdomyosarcomatous differentiation.Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC).Molecular features of thyroid oncocytic tumors.Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma.Poorly differentiated thyroid carcinoma. Are we there yet?Ectopic thyroid tissue in the adrenal gland: report of a case.New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples.Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.Contribution of microRNA analysis to characterisation of pancreatic lesions: a review.Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.Post progression survival in glioblastoma: where are we?Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis.Anaplastic thyroid carcinoma: molecular tools for diagnosis and therapy.
P50
Q21261312-3C38D973-D7AC-4441-852E-1A2F73A35095Q24303823-FB8A0E16-4021-4A46-B6F6-6124C847864BQ27025742-53A3DF00-17EA-4429-A167-AA30B7EFBB8DQ27824795-ABF448FF-3C13-4990-B91F-420560241620Q28168608-4864832A-0BB9-4E78-B201-823E9C25B876Q28730199-D596F9A8-7F39-4309-8382-CBEF0B8F39E2Q33238925-DCF491EF-DC08-48C9-B0EA-8EBF4684CE97Q33271128-7717A91A-ACC0-4FE9-B865-4BC67A9F8142Q33512669-04FC9D4D-AECA-4B3E-BC37-9D339155D2D7Q33984801-0F1A5404-F8AA-433A-9B0E-4B7C5D50C879Q34438293-22449AD2-343C-43D6-A021-EB3982697F6BQ34630607-AC1D8EC8-2EB0-4987-A972-E9DF95707289Q34716574-8D6BCAB9-CF3F-412E-AB6C-4D2B34579259Q35078128-B39A1C53-AC4F-438F-BD02-F511088A0EB1Q35087934-0E1DD33D-83A5-4109-8953-8E205E5564E1Q35218596-2BE11C6F-8A75-4D6F-AD37-9A0189336451Q35547005-846CBDEB-9EFF-4017-9EE7-BFED8E593AE0Q35994860-3FCF0724-B6ED-43B6-9039-BD184B752B9FQ36418927-7F2E2BD3-F8EE-4C4F-B845-87D03AEFA614Q36561795-D2C065AC-4550-449F-BCD9-C5523CC3D71EQ36610166-3E59807D-6D13-48D4-B1B9-1A95D4797534Q36612555-FB3D02A1-C97F-4778-BDA5-6A5677AFFD7EQ36648098-1A563702-581D-44DC-B166-9C11CCBFFFF1Q36755257-1DE31250-F0AD-40AD-9FEC-B976E1DE7555Q36909410-B74E451E-F231-43F7-85D6-6BD6E20BFA8BQ37016905-E4DDB34C-9C46-44EA-B28D-082CDED3BD0EQ37130570-272EA670-06A6-4D37-878A-3B9FF449B830Q37698708-89B32CC5-D9EE-4DED-886F-099E588F7C71Q37750412-74A75FAE-23D6-4371-8F2E-5560D4354C61Q37942063-F28F125F-2BDE-41AB-A00E-47EFF67CB99FQ38226530-63DFAFF0-A07D-4C31-A6C0-5FA2393BAFC0Q38323968-FC712FFF-3A26-4C6C-B7F1-DC6CFF83E35FQ38395259-CBD75C4F-9E6D-4008-9CCD-B28CD675EB81Q38451079-4C4435B7-B373-41C9-8F0B-CC9786386955Q38566267-05CE8038-F5BF-48CF-AE33-25B273534B0AQ38575189-60B696E8-88DB-4015-AFF3-B63DEA4FA641Q39024988-7FB80E3A-F6DB-4DEC-B94B-0D74C9A0364CQ39103916-575CCCB2-9CC2-49A4-92AB-65F5705FA409Q40583206-8AA7FE26-2846-4D08-BB84-15E743A94592Q42067797-BC5E68F8-82A5-4C81-AF80-4E9A88EE7D20
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanni Tallini
@ast
Giovanni Tallini
@en
Giovanni Tallini
@es
Giovanni Tallini
@nl
Giovanni Tallini
@sl
type
label
Giovanni Tallini
@ast
Giovanni Tallini
@en
Giovanni Tallini
@es
Giovanni Tallini
@nl
Giovanni Tallini
@sl
prefLabel
Giovanni Tallini
@ast
Giovanni Tallini
@en
Giovanni Tallini
@es
Giovanni Tallini
@nl
Giovanni Tallini
@sl
P106
P1153
7004288658
P21
P31
P496
0000-0003-0113-6682